Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Edwards Lifesciences

Where Edwards Lifesciences Stands With Analysts

Analysts have provided the following ratings for Edwards Lifesciences (NYSE:EW) within the last quarter:

Benzinga

If You Invested $100 In Edwards Lifesciences 20 Years Ago, Here's How Much You Would Have Today

Edwards Lifesciences (NYSE:EW) has outperformed the market over the past 20 years by 14.71% on an annualized basis producing an average annual return of 21.87%. Currently, Edwards Lifesciences has a market capitalization of $69.03 billion.

Benzinga

Edwards Lifesciences Clocks 10% Top-Line Growth In Q1; Forecasts Lower Than Expected Q2 Sales

Edwards Lifesciences Corp (NYSE:EW) posted a Q1 adjusted EPS of $0.60, compared to $0.54 posted a year ago and beating the consensus of $0.57. Sales increased 10% to $1.34 billion (underlying 13%), beating the consensus of $1.31 billion. Transcatheter aortic valve replacement sales grew to $881 million, up 11%. Globally, the company's…

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Medtronic vs. Edwards Lifesciences: Which Medical Device Stock is a Better Buy?

Growing demand from an aging population to track their diseases and increased focus on critical surgical procedures with lesser COVID-19 pressures on hospitals make the medical devices industry’s prospects bright. Moreover, the integration of emerging technologies and continued innovations should drive the industry’s growth. Therefore, prominent players in this space,…

StockNews.com

Recap: Edwards Lifesciences Q1 Earnings

Edwards Lifesciences (NYSE:EW) reported its Q1 earnings results on Tuesday, April 26, 2022 at 04:15 PM. Here's what investors need to know about the announcement.

Benzinga

How Too-Bullish Profit Expectations Caused Edwards Lifesciences To Crumble

Edwards Lifesciences topped Wall Street's first-quarter views on Tuesday, but EW stock fell in after-hours action.

Investors Business Daily

Dow Jones Rallies Ahead Of Powell Comments; Tesla Surges 11% On Earnings

The Dow Jones Industrial Average rallied 300 points Thursday ahead of Fed Chief Powell's comments. Tesla surged 11% on earnings results.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Dow Jones Rises, But Netflix Crashes 34% On Earnings; Tesla Earnings Due

The Dow Jones Industrial Average rose 200 points Wednesday, but Netflix crashed more than 35% on earnings. Tesla earnings are due late.

Investors Business Daily

Dow Jones Futures Rise After Market Rally; Netflix Crashes On Subscriber Fall, Tesla Earnings Due

The market rally remains under pressure and divided. Investors should keep exposure modest and focus on leading sectors.

Investors Business Daily

Dow Jones Gains As Stock Market Powers Back; Airlines Surge On Mask Mandate Move; WeWork Stock Rockets

The Dow Jones rose as the stock market powered back. Airline stocks popped on a mask mandate move. WeWork stock rocketed on a bullish call.

Investors Business Daily

Dow Jones Rises As Earnings Season Continues; Netflix Earnings On Deck

The Dow Jones Industrial Average rose Tuesday, as earnings season continues. Netflix earnings are due out after the close.

Investors Business Daily

Dow Jones Futures: What To Do After Monday's Stock Market Fall; Netflix, Tesla Earnings Ahead

Dow Jones futures were higher after Monday's stock market fall. Netflix and Tesla earnings are due out later this week.

Investors Business Daily

Investors Betting On Continued Strength In Edwards Lifesciences Stock Can Consider This Options Trade

While there's risk buying Edwards Lifesciences stock before earnings, investors can limit risk by using a bullish call spread.

Investors Business Daily

IBD Stock Of The Day Edwards Lifesciences Is Eyeing $15 Billion — And A Buy Point

Edwards Lifesciences is the IBD Stock Of The Day as the easing Covid pandemic allows for bullish growth in TAVR procedures in the U.S.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Dow Jones Climbs As Treasury Yields Continue To Rise; Twitter Reverses After Poison Pill Plan

The Dow Jones Industrial Average rose Monday, as Treasury yields extended gains. Twitter stock turned lower after adopting a poison pill plan.

Investors Business Daily

Pfizer Stock, Raytheon Lead 5 Stocks Near Buy Points

Pfizer and Raytheon are among 5 stocks near buy points that offer protection from geopolitics and aggressive rate-hikes.

Investors Business Daily

Dow Jones Futures Fall As Market Rally Weakens; Tesla Shanghai Tries To Reopen, Twitter Pops

The market rally is ailing, but not all areas. Tesla Shanghai is working to reopen with earnings due. Twitter stock popped.

Investors Business Daily

Dow Jones Rallies As Twitter Jumps On Elon Musk Buyout Offer

The Dow Jones Industrial Average rose, as Twitter stock jumped after Elon Musk offered to buy the company.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Expert Ratings for Edwards Lifesciences

Analysts have provided the following ratings for Edwards Lifesciences (NYSE:EW) within the last quarter:

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 13, 2022

Upgrades

Investors Business Daily

Dow Jones Climbs As Earnings Season Kicks Off; JPMorgan Slides On Earnings Miss

The Dow Jones Industrial Average rose Wednesday, as earnings season kicks off. JPMorgan stock slid after missing earnings estimates.

Investors Business Daily

Dow Jones Rallies After Key Inflation Report As White House Warns Of 'Extraordinarily Elevated' Inflation

The Dow Jones Industrial Average rallied Tuesday after a key inflation report following Monday's stock market sell-off.

Investors Business Daily

Dow Jones Futures: What To Do After Stock Market Sell-Off; White House Warns Of 'Extraordinarily Elevated' Inflation

Dow Jones futures were higher early. Here's what to do after Monday's stock market sell-off ahead of today's key inflation report.

Investors Business Daily

Heart Valve Maker Eyes Breakout After Getting An FDA Approval

As heart valve maker Edwards Lifesciences wins a new FDA approval, the stock looks to pump out a fresh breakout.

Investors Business Daily

Raytheon, Shell Lead Five Stocks Setting Up, Breaking Out From Strong Sectors

Raytheon Technologies and Shell are just below buy points, headlining five stocks from strong sectors.

1 2 3

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.